WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001038388) A NOVEL POLYPEPTIDE - HUMAN BRANCHED CHAIN TRANSACYLASE 31 AND A POLYNUCLEOTIDE ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/038388    International Application No.:    PCT/CN2000/000467
Publication Date: 31.05.2001 International Filing Date: 20.11.2000
Chapter 2 Demand Filed:    20.06.2001    
IPC:
A61K 38/00 (2006.01), C12N 9/16 (2006.01)
Applicants: BIOROAD GENE DEVELOPMENT LTD. SHANGHAI [CN/CN]; 12F, 3rd Building, 1111 Zhongshan Bei Er Road, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LAW OFFICES; 61 Nanjing Road (E), 11th floor, Shanghai 200002 (CN)
Priority Data:
99 1 24047.2 22.11.1999 CN
Title (EN) A NOVEL POLYPEPTIDE - HUMAN BRANCHED CHAIN TRANSACYLASE 31 AND A POLYNUCLEOTIDE ENCODING THE SAME
(FR) NOUVEAU POLYPEPTIDE - TRANSACYLASE 31 A CHAINE RAMIFIEE DE TYPE HUMAIN - ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide - Human branched chain transacylase 31 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technology. The present invention also discloses methods of using the polypeptide in treatment of various disease, such as malignant tumor, blood disease, HIV infection, immunological disease and various inflammation. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the same. The present invention also discloses the use of such polynucleotide encoding Human branched chain transacylase 31.
(FR)L'invention concerne un nouveau polypeptide - transacylase 31 à chaîne ramifiée de type humain - et un polynucléotide codant ce polypeptide, ainsi qu'un procédé pour la production du polypeptide par technologie de recombinaison de l'ADN. L'invention concerne également des procédés relatifs à l'utilisation du polypeptide dans le traitement de diverses maladies: par exemple, tumeurs malignes, maladies du sang, infection par le VIH, maladies immunitaires et différentes catégories d'inflammation. L'invention concerne enfin un antagoniste vis-à-vis du polypeptide et son utilisation thérapeutique, ainsi que l'utilisation du polynucléotide qui le code.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)